8-K: Avinger Inc. Faces Liquidation After Defaulting on Loan Agreement

Avinger Inc. has defaulted on its loan agreement and is proposing an assignment for the benefit of creditors followed by a voluntary dissolution and liquidation.

Summary

• Avinger Inc. has filed a preliminary proxy statement for a special meeting of stockholders scheduled for January 17, 2025.
• The proposal includes an assignment for the benefit of creditors followed by a voluntary dissolution and liquidation.
• This proposal is considered an event of default under their loan agreement with CRG Partners III L.P.
• Avinger also notified CRG that they are not in compliance with a $3.5 million minimum liquidity covenant, which is also an immediate event of default.
• As of December 11, 2024, approximately $2.8 million in principal and interest is outstanding under the CRG Agreement.
• The assignment would transfer control of Avinger's assets to an assignee who will liquidate them to satisfy creditor obligations.
• It is unlikely that common stockholders will receive any distribution after the liquidation.
• Avinger's common stock is expected to be delisted from Nasdaq if the assignment and dissolution are approved.

Sentiment

Score: 1

Explanation: The document indicates a severe financial crisis for Avinger, with a proposed liquidation and no expected return for common stockholders. This is a highly negative outcome for investors.

Negatives

• Avinger has defaulted on its loan agreement.
• The company is proposing an assignment for the benefit of creditors followed by a voluntary dissolution and liquidation.
• The company is not in compliance with a $3.5 million minimum liquidity covenant.
• Common stockholders are unlikely to receive any distribution from the liquidation.
• Avinger's stock is expected to be delisted from Nasdaq.

Risks

• The assignment for the benefit of creditors may not achieve the intended results or may result in lower-than-expected recoveries for creditors.
• The potential breach of the loan agreement could lead to enforcement actions by lenders.
• There is a risk that stockholders may not approve the assignment and dissolution.
• The company's future financial condition, operations, or prospects are uncertain.

Future Outlook

The company plans to pursue an assignment for the benefit of creditors followed by a voluntary dissolution and liquidation, subject to stockholder approval. The company's common stock is expected to be delisted from Nasdaq.

Management Comments

• The company's board of directors will deem the assignment and dissolution to be in the best interests of the company and its stockholders.
• The company does not know whether any amounts will be available for distribution to holders of its common stock.

Industry Context

This announcement reflects significant financial distress for Avinger, a medical device company. The proposed liquidation is a drastic measure, indicating the company's inability to continue as a going concern. This situation is not uncommon in the medical device industry, where companies face high development costs and regulatory hurdles.

Comparison to Industry Standards

• Avinger's situation is comparable to other small medical device companies that have struggled with profitability and debt.
• Many early-stage medical device companies rely heavily on venture capital and debt financing, making them vulnerable to financial distress if they fail to achieve commercial success.
• The proposed liquidation is a common outcome for companies that cannot meet their debt obligations and fail to secure additional funding.
• Companies like Hansen Medical (acquired by Auris Health) and ReWalk Robotics have faced similar financial challenges, highlighting the risks associated with the medical device sector.

Stakeholder Impact

• Shareholders are likely to lose their investment as it is unlikely they will receive any distribution.
• Creditors will receive distributions from the liquidation of the company's assets.
• Employees will likely lose their jobs as the company ceases operations.
• Customers and suppliers will be impacted by the company's closure.

Next Steps

• The company will file a definitive proxy statement on Schedule 14A.
• Stockholders will vote on the assignment and dissolution proposal at the special meeting on January 17, 2025.
• If approved, the company will proceed with the assignment for the benefit of creditors and subsequent liquidation.
• The company's common stock is expected to be delisted from Nasdaq.

Key Dates

Keywords

liquidation, default, assignment for the benefit of creditors, dissolution, loan agreement, bankruptcy, delisting, CRG Partners, insolvency